Over 25 years of scientific research and clinical studies involving both animals and humans have been conducted on CMRT technology by leading scientists and medical researchers at the following institutions:
The resulting studies indicate the effects of non-ionizing pico-Tesla level electromagnetic fields on biological systems when applied to a diverse range of study areas including:
The Relaxation Response is an introduction to Clinical Magnetic Resonance Therapy by its founder Dr. Jerry Jacobson. It includes summaries of ten research studies conducted over two decades:
Daniel Sohinki, MD, MS 1, Stavros Stavrakis, MD, PhD 2, Sunny Po, MD, PhD 2, Julie A. Stoner, PhD 2, Benjamin J. Scherlag, PhD 2
1 Medical College of Georgia, Augusta University, Augusta, Georgia
2 University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
(Nov 2019)
Paul J. Garabelli 1, Blake T. Morris 1, Kailee N. May 2, Xichun Yu 3, Stavros Stavrakis 1, Benjamin J. Scherlag 1 and Sunny Clinical Research PDFs for website S. Po 1
1 University of Oklahoma Health Science Center, Cardiovascular Diseases Section, USA; 2 University of Oklahoma College of Medicine, USA; 3 University of Oklahoma Health Science Center, Diabetes and Endocrinology Section, USA. (2018)
Jerry I Jacobson, Institute of Theoretical Physics and Advanced Studies for Biophysical Research, Jupiter, FL, USA (2016)
Jerry I. Jacobson, Institute of Theoretical Physics and Advanced Studies for Biophysical Research, Jupiter, FL, USA (2016)
Jacobson J I, Institute of Theoretical Physics and Advanced Studies for Biophysical Research, Jupiter, Florida, USA
Published in Innovation Energy & Research 2016, 5:1
Lilei Yu, MD 1, John W. Dyer, PhD 2, Benjamin J. Scherlag, PhD 2, Stavros Stavrakis, MD, PhD 2, Yong Sha, MD 2, Xia Sheng, MD 2, Paul Garabelli, MD 2, Jerry Jacobson, DMD, PhD 3, Sunny S. Po, MD, PhD 2
1 Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China; 2 Heart Rhythm Institute and Department of Medicine, Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; 3 Pico-Telsa Therapies LLC, Littleton, Colorado (2015)
Songyn Wang 1, Xiaoya Zhou 1, Zhuo Wang 1, Bing Huang 1, Liping Zhou 1, Mingxian Chen 2, Lilei Yu 1, Hing Jiang 1
1 Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, Hubei, China; 2 Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China
International Journal of Cardiology 190 (2015) 54-55
Yao Wang 1,2, Marie K. Hensley 1, Allan Tasman 1, Lonnie Sears 1, Manuel F. Casanova 1, Estate M. Sokhadze 1
1. University of Louisville, KY, USA
2. State Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China (2015)
Jerry Jacobson 1, Benjamin Sherlag 2,
1. Institute of Theoretical Physics and Advanced Studies for Biophysical Research, Jupiter, Florida, USA; 2. Department of Medicine, Cardiovascular Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA (2015)
By Jerry Jacobson, DMD, PhD, IOM
Published in The American Chiropractor September 2015
Jerry Jacobson 1, Benjamin Sherlag 2
1 Institute of Theoretical Physics and Advanced Studies for Biophysical Research, Jupiter, FL, USA 2; Department of Medicine, Cardiovascular Section, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA (2015)
Jacobson J I, Institute of Theoretical Physics and Advanced Studies for Biophysical Research, Jupiter, Florida, USA
International Journal of Clinical & Medical Imaging, August, 2015
O. Klepitskaya 1, R. Kumar 2 (2009)
1 University of Colorado Health Sciences Center, Department of Neurology, Aurora, CO, USA
2 Colorado Neurological Institute Movement Disorder Center, Englewood, CO, USA.
By Jerry Jacobson, PhD, DMD, IOM
Published in Dynamic Chiropractic – July 15, 2013, Vol. 31, Issue 14
Chao Qin, MD, PhD 1, J. Mark Evans, MD 1, William S. Yamanashi 2, PhD, Benjamin J. Scherlag, MD 2, Robert D. Foreman, PhD 1
Departments of 1 Physiology and 2 Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
© 2005 International Neuromodulation Society
Benjamin J. Scherlag 1, PhD, William S. Yamanashi 1, PhD, Yuemei Hou MD 2, PhD, Jerry I. Jacobson 3, PhD, Warren M. Jackman 1, MD, Ralph Lazzara, MD 1
1. Cardiac Arrhythmia Research Institute at the University of Oklahoma Medical Center, Oklahoma, USA
2. Xingjiang Medical University, Urumuqui, PR, China
3. Jacobson Resonance Enterprises, Boynton Beach, Florida
C.Todd Trostel, DVM; Ron M. McLaughlin, DVM, DVSc; John G. Lamberth, PhD; Robert C. Cooper, DVM, MS; Steven H. Elder, PhD; Roy R. Pool, DVM, PhD; Cheng Gao, DDS, MS; Joseph A. Cromiak, PhD; Carolyn R. Boyle, PhD
From the Departments of Clinical Sciences (Trostel, McLaughlin, Cooper), Pathobiology and Population Medicine (Pool), and Basic Sciences (Gao, Boyle), College of Veterinary Medicine; the Department of Health, Physical Education, Recreation, and Sport (Lamberth, Cromiak), College of Education; and the Department of Agricultural and Biological Engineering (Elder), College of Agriculture and Life Sciences, Mississippi State University, Mississippi State, MS.
American Journal of Veterinary Research, Vol 64, No. 7, July 2003
Anjali Saxena,1 Jerry Jacobson,2 William Yamanashi,2 Benjamin Scherlag,3 John Lamberth,4 Brij Saxena 5
1. Department of Biological Sciences, Fairleigh Dickinson University, Teaneck, New Jersey, USA.
2. Institute of Theoretical Physics and Advanced Studies for Biophysical Research, Perspectivism Foundation, 2006 Mainsail Circle, Jupiter, Florida 33477, USA.
3. Department of Medicine, Cardiovascular Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
4. Department of Recreation, Sports and Physical Therapy, Mississippi State University, Mississippi, USA.
5 Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Weill Medical College of Cornell University, NY, USA.
J.I. Jacobson 1, R. Gorman 1, F. Chaviano 1, W.S. Yamanashi 2, I. Grinberg 3, M. Dayton 4, S. Haltiwanger 5, B. B. Saxena 6, B. Walters 7, L. Clayton 8, J. Lamberth 9
1. Institute of Theoretical Physics and Advanced Studies for Biophysical Research,
National Medical Research Institute, Department of Medical Physics and Neuromagnetics Boca Raton, Fla.
2. Department of Medicine, Cardiac Arrhythmia Research Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Okla.
3. West Gables Rehabilitation Outpatient Center Hospital, Coral Gables, FL, USA
4. Dayton Medical Center, Miami FL, USA
5. Emanuel Medical Center, Roswell, GA, USA
6. Department of Obstetrics/Gynecology, Division of Reproductive Endocrinology, Cornell University Medical College, NY, USA
7. Outcomes Analysis Corporation, Dania Beach, FL, USA
8. Prototyping Laboratory, John C. Stennis Space Center, MS, USA
9. Mississippi State University
Dr. Pedro Alonso Atienza; Costa del Sol Hospital, Marbella, Spain
Dr. Joaquin Garcia Montes; Serrania Ronda Hospital, Spain
Safety & Risk Studies
Five Institutional Review Boards (IRBs), including Independent Review Consulting, Inc. IRB, Western Investigational Review Board (WIRB), University of Colorado’s IRB (COMIRB), Ethical & Independent Review Services, and University of South Florida’s IRB have determined the predecessor to the CMRT Device, the Jacobson Resonator™, to be a non-significant risk (NSR) device when applied to the particular studies and protocols identified below. These protocols involved Parkinson Disease, Alzheimer Disease, Fibromyalgia, and Type 2 Diabetes patients for eight independent studies, as described below:
Efficacy of the application of magnetic fields to the treatment of Parkinson’s disease pilot study protocol, APPLIED MAGNETICS, LLC. Version 1.6, February 20, 2007. IRC study # 07021-02.
A double-blind, sham-stimulation controlled study of the application of magnetic fields using the Jacobson Resonator™ for the treatment of Parkinson’s disease: phase two pilot study protocol. Version 2.5, Oct 2007. IRC # 07102-01.
An open label extension study for subjects previously treated in either pilot I or pilot II studies of the application of magnetic fields using the Resonator™ for the treatment of Parkinson’s disease: Extension pilot study protocol, Version 4.0, March 14, 2008. IRC# 06052-01.IRC Resonator Device NSR #: DAM-003.
A controlled pilot study of the application of magnetic fields using the Resonator™ in adjunctive management of Type 2 Diabetes; Version 1.8, December 2, 2008; Pico-Tesla Magnetic Therapies, LLC., a subsidiary of APPLIED MAGNETICS, LLC. IRC # 08165-01
A randomized, double-blind, placebo-controlled study of the application of magnetic fields using the Resonator™ in adjunctive management of Type 2 Diabetes Mellitus, pilot study II. IRC # 09109-01
A multiple site, randomized, double-blind, sham-stimulation controlled study of the application of magnetic fields using the Resonator™ device for the treatment of Parkinson’s disease; Pico-Tesla Magnetic Therapies, LLC. April 7, 2010. IRC # 09026:
A single site, randomized, single-blind, placebo-controlled study to evaluate the safety and efficacy of the application of magnetic fields using the Resonator for the treatment of Alzheimer’s Disease in addition to standard of care, Pico-Tesla Magnetic Therapies, LLC. October 12, 2010. USF IRB Study # Pro00001676
A randomized, double-blind, placebo-controlled, evaluation of the application of magnetic fields using the Resonator™ device for the treatment of fibromyalgia: pilot study protocol. Pico-Tesla Magnetic Therapies, LLC. November 2, 2010, E&I Review Services Study # 10242-01
Clinical Research Disclaimer
All research and clinical material is for informational purposes only. Readers are encouraged to confirm the information contained herein with other sources. The information is not intended to replace medical advice offered by physicians.